Supplements
What Causes Dry Eyes with Fibroids?
Dry eyes and uterine fibroids rarely get discussed together, yet both conditions share a striking hormonal overlap. When estrogen dominance suppresses tear-film quality and inflames meibomian glands simultaneously, treating either symptom in isolation often fails. Understanding the shared root causes is the first step toward relief.

What Causes Dry Eyes with Fibroids?
Yes, dry eyes and fibroids genuinely share a root cause. Both conditions are strongly linked to estrogen dominance — a state where estrogen is disproportionately high relative to progesterone. Excess estrogen drives fibroid growth and simultaneously alters tear-film lipid composition, reducing the eye's ability to stay lubricated. The exception: some women with fibroids have dry eyes from entirely separate causes (thyroid dysfunction, nutritional deficiencies, or autoimmune activity), so symptoms need biomarker-level investigation.
---
How Estrogen Dominance Connects Fibroids and Dry Eyes
Uterine fibroids are estrogen-sensitive, smooth-muscle tumors. Research shows fibroid tissue expresses estrogen receptor-alpha at concentrations roughly three times higher than surrounding myometrium, which is why fibroid growth accelerates during reproductive years and regresses after menopause (Flake et al., Seminars in Reproductive Medicine 2003; PMID: 12772089).
What is less widely known is that ocular surface health is also hormonally regulated. Meibomian glands — the oil-secreting glands along the eyelid margin that prevent tear evaporation — respond directly to sex hormones. Androgens (testosterone and DHEA) stimulate meibomian gland secretion; estrogen, in excess and without progesterone balance, suppresses androgen receptor signaling and reduces lipid output from these glands (Sullivan et al., Advances in Experimental Medicine and Biology 2002; PMID: 12396075). Less meibum means faster tear evaporation, which clinically presents as dry, gritty, or burning eyes.
The mechanism runs in both directions. Elevated estrogen suppresses androgen conversion, meibomian gland function declines, and the aqueous tear layer becomes unstable. Women with polycystic ovary syndrome (PCOS) — another estrogen-dominant / androgen-disrupted condition — show significantly higher rates of dry eye syndrome compared to age-matched controls (Gonen et al., Cornea 2014; PMID: 24557085), reinforcing that hormonal imbalance is a plausible shared driver.
If you are also experiencing dry skin changes alongside fibroids, the same estrogen-progesterone imbalance is almost certainly involved across multiple tissue systems, not just the eyes.
---
Stress as a Major Amplifier: Why Flare-Ups Happen
One of the most underappreciated contributors to both fibroid symptoms and ocular surface dysfunction is the cortisol-to-progesterone steal. Under chronic stress, the adrenal glands preferentially synthesize cortisol using progesterone as a precursor substrate — a phenomenon sometimes called "progesterone steal" or the "cortisol shunt." The result is a relative drop in circulating progesterone, which allows estrogen to go functionally unopposed.
For many women, this explains why fibroid pain, bloating, and — yes — dry eye symptoms worsen during high-stress periods. Cortisol elevation also directly promotes pro-inflammatory cytokines (IL-1β, TNF-α) that degrade the mucin layer of the tear film (Stern et al., The Ocular Surface 2010; PMID: 20045867), creating a secondary inflammatory pathway for dry eye independent of meibomian gland dysfunction.
Practical stress-management strategies that have evidence behind them include:
- Diaphragmatic breathing protocols (5–10 minutes, twice daily) shown to lower salivary cortisol in randomized controlled trials
- Adaptogenic herb supplementation — covered in detail below
- Sleep optimization — poor sleep raises morning cortisol by 20–30%, compounding hormonal disruption over time
- Reducing glycemic load — insulin spikes stimulate ovarian androgen production and further disrupt sex hormone balance
Tracking stress biomarkers (4-point salivary cortisol, DHEA-S, fasting insulin) alongside reproductive hormones gives a far clearer picture than symptom questionnaires alone. For a detailed breakdown of how chronic adrenal burden connects to systemic fatigue and inflammation, the article on supplements for adrenal fatigue and root causes is worth reviewing alongside the hormonal workup described here.
---
The Biomarkers Worth Checking
Not every case of dry eyes in a woman with fibroids has the same driver. A targeted panel separates estrogen-dominant cases from thyroid-related, nutritional, or autoimmune presentations.
| Biomarker | Optimal Range | What It Tells You |
|---|---|---|
| Estradiol (E2) | 30–100 pg/mL (follicular) | Elevated E2 without corresponding progesterone confirms dominance |
| Progesterone | 5–25 ng/mL (luteal) | Low luteal progesterone relative to estradiol is the key ratio |
| DHEA-S | 150–350 µg/dL (women) | Low DHEA-S correlates with meibomian gland dysfunction |
| Free testosterone | 1.0–8.5 pg/mL | Very low free T also impairs meibomian secretion |
| TSH + Free T4 + Free T3 | TSH 0.5–2.5 mIU/L | Hypothyroidism causes dry eyes independently of estrogen |
| hs-CRP | <1.0 mg/L | Elevated CRP signals systemic inflammation affecting tear film |
| Vitamin D (25-OH) | 50–80 ng/mL | Deficiency linked to both fibroid growth and ocular surface inflammation |
| Omega-3 Index | >8% | Low omega-3 index is a strong independent predictor of dry eye |
Thyroid dysfunction deserves its own mention. Hypothyroidism reduces aqueous tear production and causes meibomian gland dropout — and it is comorbid with fibroids more often than chance would predict, partly because thyroid receptor function depends on progesterone signaling. If you're researching the overlap between dry eyes, perimenopause, and hypothyroidism, the biomarker pattern differs meaningfully from pure estrogen dominance and warrants separate attention.
Similarly, women who also struggle with itchy or inflamed skin alongside fibroids often show elevated hs-CRP and histamine — signs that mast cell activation and systemic inflammation are contributing to their symptom cluster.
---
Nutritional Deficiencies That Worsen Both Conditions
Even when hormonal imbalance is the primary driver, nutritional gaps accelerate tear-film breakdown and fibroid-related inflammation. The following deficiencies are worth quantifying:
Omega-3 fatty acids (EPA + DHA): A 12-week randomized controlled trial found that 2,000 mg/day of combined EPA/DHA significantly improved Ocular Surface Disease Index (OSDI) scores and tear-break-up time compared to placebo in patients with dry eye syndrome (Bhargava et al., Contact Lens & Anterior Eye 2015; PMID: 25453523). EPA also competes with arachidonic acid for cyclooxygenase enzymes, reducing prostaglandin-driven inflammation that fuels fibroid growth.
Vitamin D3: Vitamin D receptors are found in uterine smooth muscle, and low 25-OH vitamin D is independently associated with a 32% higher prevalence of fibroids in large epidemiological studies (Baird et al., Epidemiology 2013; PMID: 23442498). On the ocular side, vitamin D has immunomodulatory effects on the conjunctival epithelium and reduces inflammatory cytokine production that degrades the mucin layer.
Magnesium: Magnesium modulates estrogen metabolism through CYP1B1 enzyme activity and supports COMT (catechol-O-methyltransferase) function, which is the primary hepatic route for estrogen clearance. Magnesium deficiency slows estrogen detoxification and elevates circulating estrogen levels — a pathway directly relevant to both fibroids and hormonal dry eye.
Zinc: Zinc is required for 5-alpha reductase activity that converts precursors to androgens, including DHEA. Low zinc contributes to androgen deficiency at meibomian glands. Serum zinc below 70 µg/dL is worth supplementing.
---
What About Inflammation and the Tear Film?
Beyond hormones and nutrition, systemic low-grade inflammation — common in women with large or multiple fibroids — directly degrades ocular surface integrity. Fibroids shed pro-inflammatory cytokines into systemic circulation. Elevated IL-6, TNF-α, and prostaglandin E2 have all been measured at higher levels in women with fibroids compared to controls.
These same inflammatory mediators destabilize the aqueous and mucin layers of the tear film, increase tear osmolarity, and activate sensory nerve pathways that cause the burning, foreign-body sensation characteristic of dry eye disease. In other words, even if estrogen dominance is well-controlled, untreated systemic inflammation from fibroid burden can perpetuate dry eye symptoms independently.
This is also why chronic fatigue is so frequently reported alongside fibroids and dry eye — elevated inflammatory cytokines suppress mitochondrial function and drive the persistent exhaustion many women with fibroids describe.
Anti-inflammatory lifestyle interventions (Mediterranean-pattern diet, reduced ultra-processed food intake, regular aerobic activity) produce measurable drops in hs-CRP within 8–12 weeks and represent foundational support before or alongside targeted supplementation.
---
What This Means for Your Formula
If your blood work confirms estrogen dominance, low omega-3 index, suboptimal vitamin D, and elevated inflammatory markers, those findings map to specific ingredients at clinical doses — not a generic multivitamin.
Omega-3 (EPA/DHA): Ones includes pharmaceutical-grade omega-3 dosed to provide meaningful EPA and DHA, calibrated to your omega-3 index result. The target is moving your index above 8%, the threshold associated with reduced dry eye severity and reduced prostaglandin-driven tissue inflammation.
Vitamin D3 + K2 (MK-7): Ones pairs D3 with vitamin K2 as MK-7 to support calcium metabolism alongside the immune-regulatory and estrogen-receptor-modulating effects of D3. Dosing is personalized to your 25-OH vitamin D baseline — common clinical targets for deficient individuals range from 2,000 to 5,000 IU/day, adjusted until serum levels reach 50–80 ng/mL.
Adrenal Support (Ones System Blend): For women whose dry eye and fibroid flares track with stress cycles, the cortisol-progesterone steal is a key leverage point. Ones' proprietary Adrenal Support blend targets HPA-axis regulation using a combination of adaptogenic and adrenal-supporting botanicals dosed at clinical ranges. This complements dietary and lifestyle stress reduction without replacing medical evaluation of cortisol burden.
Ones' AI practitioner synthesizes your lab results, wearable data (including sleep quality metrics relevant to cortisol rhythm), and health history to build a formula that addresses the actual biomarker pattern — not a symptom checklist. If your dry eyes are thyroid-driven rather than estrogen-driven, the formula reflects that distinction.
---
Key Takeaways
- Estrogen dominance is the shared root cause of both uterine fibroids and hormonal dry eye in most premenopausal women — excess estrogen suppresses androgen signaling, which degrades meibomian gland output and tear-film stability.
- Stress worsens both conditions through the cortisol-progesterone steal: high cortisol depletes progesterone, allowing estrogen to go unopposed and inflammatory cytokines to rise.
- The biomarkers that matter most are the estradiol-to-progesterone ratio, DHEA-S, free testosterone, TSH/Free T3, 25-OH vitamin D, omega-3 index, and hs-CRP — not just a single hormone panel.
- Omega-3 (EPA/DHA) and vitamin D3 have the strongest evidence for both ocular surface improvement and anti-fibroid inflammatory effects; deficiencies in both are common and measurable.
- Systemic inflammation from fibroid burden can perpetuate dry eye independently of hormone levels, meaning hormonal optimization alone may be insufficient without anti-inflammatory support.
- Personalized, biomarker-driven supplementation outperforms generic eye health or women's health formulas because the underlying driver varies — hypothyroidism, omega-3 deficiency, and estrogen dominance require different interventions even when symptoms look identical.
---
This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement protocol, particularly if you have diagnosed uterine fibroids or a history of hormone-sensitive conditions.
---
References
- Flake GP et al. Etiology and pathogenesis of uterine leiomyomas: a review. Seminars in Reproductive Medicine 2003; PMID: 12772089
- Sullivan DA et al. Androgen deficiency, meibomian gland dysfunction, and evaporative dry eye. Advances in Experimental Medicine and Biology 2002; PMID: 12396075
- Gonen T et al. The association between polycystic ovary syndrome, obesity, and dry eye. Cornea 2014; PMID: 24557085
- Stern ME et al. The role of the lacrimal functional unit in the pathophysiology of dry eye. The Ocular Surface 2010; PMID: 20045867
- Bhargava R et al. Oral omega-3 fatty acids treatment in computer vision syndrome related dry eye. Contact Lens & Anterior Eye 2015; PMID: 25453523
- Baird DD et al. Vitamin D and the risk of uterine fibroids. Epidemiology 2013; PMID: 23442498